Plant Comparison
Panax Ginseng vs Oyster mushroom
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Panax Ginseng and Oyster mushroom: they share 8 indicated uses (arthritis / joint pain, blood sugar / diabetes support, cardiovascular / heart health, …); 4 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Panax Ginseng | Oyster mushroom | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 5/10 | 5/10 | Comparable evidence |
| Blood sugar / diabetes support | 5/10 | 6/10 | Comparable evidence |
| Cardiovascular / heart health | 5/10 | 6/10 | Comparable evidence |
| Cold & flu | 5/10 | 6/10 | Comparable evidence |
| Immune support | 5/10 | 7/10 | Stronger for Oyster mushroom |
| Inflammation (general) | 5/10 | 5/10 | Comparable evidence |
| Metabolic support | 5/10 | 6/10 | Comparable evidence |
| Skin irritation | 5/10 | 5/10 | Comparable evidence |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
The principal bioactive triterpene saponins of the root, considered responsible for most of ginseng's adaptogenic, neuroprotective and immunomodulatory activity; the ratio of protopanaxadiol- to protopanaxatriol-type ginsenosides differs between fresh, white and red ginseng.
Contribute to the immunomodulatory activity of the root.
Minor constituents contributing to the aroma and antioxidant activity.
The principal bioactive constituents, responsible for most of the mushroom's immunomodulatory and anticancer activity.
Contribute to immunomodulatory activity alongside the pure beta-glucans.
Contribute to the antioxidant activity of the fruiting body.
Pharmacological Actions
Traditional & Indicated Uses
inferred from anti-inflammatory action
inferred from antidiabetic action
inferred from neuroprotective action
inferred from immunomodulator action
inferred from ergogenic action
inferred from anti-inflammatory action
inferred from ergogenic action
inferred from anti-inflammatory action
inferred from antidiabetic action
inferred from anticancer action
inferred from anti-inflammatory action
inferred from antidiabetic action
inferred from anti-inflammatory action
Safety, Cautions & Contraindications
Generally well tolerated in short-term use (up to 3 months). May cause insomnia, headache, or gastrointestinal upset at high doses. Avoid during pregnancy and breastfeeding. May interact with warfarin, MAOIs, and diabetic medications. Not recommended for continuous use without breaks.
Duke (2002) rates Korean/Oriental ginseng (Panax ginseng) as highly active with clinical support for adaptogenic, immunostimulant, and performance-enhancing effects. Commission E approves standardized ginseng root extract (4–7% ginsenosides) as a tonic for fatigue and during convalescence. Dose: 200–600 mg standardized extract daily. Duke cautions about 'Ginseng Abuse Syndrome' (GAS) with overdose — symptoms include hypertension, insomnia, edema, and nervousness. Drug interactions are notable: ginseng potentiates MAOIs and may interact with warfarin, digoxin, and stimulants. Cycle use (2–3 weeks on, 2 weeks off) is recommended (Duke, 2002).
Generally very safe as a food. Rare cases of occupational asthma and allergy reported among people working with mushroom cultivation. Safe for culinary use without significant known interactions.
External Ids
Botanical Description
Slow-growing perennial herb (Araliaceae), 30-60 cm tall, harvested at 4 years of age or older. A single erect stem bears a whorl of palmately compound leaves, each with 3-5 toothed leaflets, at its top. Small greenish-white flowers are borne in a single terminal umbel, followed by small red berries. The fleshy, often forked or human-shaped taproot - the origin of the name 'ginseng' ('renshen', man-root) - is the medicinal part.[3]
Wood-decay fungus (not a true plant, Pleurotaceae) that grows in shelf-like, overlapping clusters on dead or dying hardwood trees and stumps. Fan- or oyster-shell-shaped caps, 5-25 cm across, are usually grey, tan or brown (occasionally pale or white), with white gills running down a short, off-centre stem. The mycelium is a fine white network that colonises and decomposes the wood substrate before fruiting.
Habitat
Native to the cool-temperate deciduous mountain forests of Manchuria, Korea and the Russian Far East. Historically wild-harvested, it is now predominantly cultivated, mainly in Korea and China, under artificial shade for several years before harvest.[1]
Grows naturally on dead or dying broadleaf (hardwood) trees - beech, oak, poplar and others - in temperate forests worldwide; widely cultivated commercially on straw, sawdust and other lignocellulosic substrates.
Harvesting
The root is harvested after at least 4-6 years of growth, once its ginsenoside content is fully developed. Roots are either air-dried as 'white ginseng' or steamed and then dried as 'red ginseng', a processing step that alters the ginsenoside profile.[3]
Wild fruiting bodies are picked as the caps mature but before they become tough or insect-damaged; cultivated mushrooms are harvested from substrate blocks or bags once the caps have expanded but before releasing significant spore load. Never forage a white shelf-fungus from wood without confirming the host tree, since the fatal Angel Wing look-alike is specific to conifer (softwood) wood.[14]
Traditional Uses
Ginseng is one of the most celebrated tonic herbs of East Asian traditional medicine, used for millennia as a general adaptogen to restore vitality, support recovery from illness and improve stamina and cognitive performance. Modern clinical research supports adaptogenic, immunomodulatory, antioxidant, neuroprotective and mild antidiabetic effects consistent with this traditional use.[1, 7]
Oyster mushroom is a widely eaten culinary mushroom with a growing modern reputation as a medicinal fungus, valued for immune support and general wellbeing. Contemporary research on its beta-glucan polysaccharides supports immunomodulatory, antioxidant, anticancer and cardiometabolic activity.[1, 5]
Preparations
Commission E-recognised standardised extract (4-7% ginsenosides), the most clinically studied preparation.
Traditional processed form (steamed then dried), which alters and concentrates the ginsenoside profile compared with white (unprocessed) ginseng.
Dosage
References
Drug Class Interactions
Not documented
Pairings
Ginseng and feverfew both reduce blood clotting/platelet stickiness, so taking them together may add up and raise the risk of bruising or bleeding — use caution, especially before surgery or alongside blood-thinning drugs.[19, 20]
Ginseng and ginger both reduce blood clotting/platelet stickiness, so taking them together may add up and raise the risk of bruising or bleeding — use caution, especially before surgery or alongside blood-thinning drugs.[19, 21]
Not documented
Lookalikes Review
Dangerous Lookalikes
Not documented
References & Sources
- Mancuso, C. and Santangelo, R (2017) 'Panax ginseng and Panax quinquefolius: From pharmacology to toxicology', Food and Chemical Toxicology, 107(Pt A), pp. 362-372. doi:10.1016/j.fct.2017.07.019 Meta-analysis / review
https://doi.org/10.1016/j.fct.2017.07.019 - Zhou, Z., Li, M., Zhang, Z., Song, Z. and others (2024) 'Overview of Panax ginseng and its active ingredients protective mechanism on cardiovascular diseases', Journal of Ethnopharmacology, 334, pp. 118506. doi:10.1016/j.jep.2024.118506 Meta-analysis / review
https://doi.org/10.1016/j.jep.2024.118506 - Liu, H., Lu, X., Hu, Y. and Fan, X (2020) 'Chemical constituents of Panax ginseng and Panax notoginseng explain why they differ in therapeutic efficacy', Pharmacological Research, 161, pp. 105263. doi:10.1016/j.phrs.2020.105263 Meta-analysis / review
https://doi.org/10.1016/j.phrs.2020.105263 - Fan, S., Zhang, Z., Su, H., Xu, P. and others (2020) 'Panax ginseng clinical trials: Current status and future perspectives', Biomedicine & Pharmacotherapy, 132, pp. 110832. doi:10.1016/j.biopha.2020.110832 Meta-analysis / review
https://doi.org/10.1016/j.biopha.2020.110832 - Ni, X.C., Wang, H.F., Cai, Y.Y., Yang, D. and others (2022) 'Ginsenoside Rb1 inhibits astrocyte activation and promotes transfer of astrocytic mitochondria to neurons against ischemic stroke', Redox Biology, 54, pp. 102363. doi:10.1016/j.redox.2022.102363 Preclinical
https://doi.org/10.1016/j.redox.2022.102363 - Arring, N.M., Millstine, D., Marks, L.A. and Nail, L.M (2018) 'Ginseng as a Treatment for Fatigue: A Systematic Review', Journal of Alternative and Complementary Medicine, 24(7), pp. 624-633. doi:10.1089/acm.2017.0361 Meta-analysis / review
https://doi.org/10.1089/acm.2017.0361 - Zhou, G., Wang, C.Z., Mohammadi, S., Sawadogo, W.R. and others (2023) 'Pharmacological Effects of Ginseng: Multiple Constituents and Multiple Actions on Humans', The American Journal of Chinese Medicine, 51(5), pp. 1085-1104. doi:10.1142/S0192415X23500507 Meta-analysis / review
https://doi.org/10.1142/S0192415X23500507 - Ramanathan, M.R. and Penzak, S.R (2017) 'Pharmacokinetic Drug Interactions with Panax ginseng', European Journal of Drug Metabolism and Pharmacokinetics, 42(4), pp. 545-557. doi:10.1007/s13318-016-0387-5 Meta-analysis / review
https://doi.org/10.1007/s13318-016-0387-5 - Li, J., Huang, Q., Chen, J., Qi, H. and others (2021) 'Neuroprotective Potentials of Panax Ginseng Against Alzheimer's Disease: A Review of Preclinical and Clinical Evidences', Frontiers in Pharmacology, 12, pp. 688490. doi:10.3389/fphar.2021.688490 Meta-analysis / review
https://doi.org/10.3389/fphar.2021.688490 - Geng, J., Dong, J., Ni, H., Lee, M.S. and others (2010) 'Ginseng for cognition', Cochrane Database of Systematic Reviews, (12), pp. CD007769. doi:10.1002/14651858.CD007769.pub2 Meta-analysis / review
https://doi.org/10.1002/14651858.CD007769.pub2 - Attele, A.S., Wu, J.A. and Yuan, C.S (1999) 'Ginseng pharmacology: multiple constituents and multiple actions', 58(11), pp. 1685--1693. doi:10.1016/s0006-2952(99)00212-9 Traditional / reference
https://doi.org/10.1016/s0006-2952(99)00212-9 - Kiefer, D. and Pantuso, T (2003) 'Panax ginseng', 68(8), pp. 1539--1542. Traditional / reference
https://scholar.google.com/scholar?q=Panax%20ginseng - Park, H.J., Kim, D.H. and Park, S.J (2014) 'Ginseng in traditional herbal prescriptions', 38(1), pp. 1--7. doi:10.5142/jgr.2012.36.3.225 Randomized trial
https://doi.org/10.5142/jgr.2012.36.3.225 - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Izzo, A.A. and Ernst, E (2009) 'Interactions between herbal medicines and prescribed drugs: an updated systematic review', Drugs, 69(13), pp. 1777-1798. doi:10.2165/11317010-000000000-00000 Meta-analysis / review
https://doi.org/10.2165/11317010-000000000-00000 - Yuan, C.S., Wei, G., Dey, L., Karrison, T., Nahlik, L., Maleckar, S., Kasza, K., Ang-Lee, M. and Moss, J (2004) 'American ginseng reduces warfarin's effect in healthy patients: a randomized, controlled trial', Annals of Internal Medicine, 141(1), pp. 23-27. doi:10.7326/0003-4819-141-1-200407060-00011 Randomized trial
https://doi.org/10.7326/0003-4819-141-1-200407060-00011 - Sotaniemi, E.A., Haapakoski, E. and Rautio, A (1995) 'Ginseng therapy in non-insulin-dependent diabetic patients', Diabetes Care, 18(10), pp. 1373-1375. doi:10.2337/diacare.18.10.1373 Randomized trial
https://doi.org/10.2337/diacare.18.10.1373 - Vuksan, V., Sievenpiper, J.L., Koo, V.Y., Francis, T., Beljan-Zdravkovic, U., Xu, Z. and Vidgen, E (2000) 'American ginseng (Panax quinquefolius L) reduces postprandial glycemia in nondiabetic subjects and subjects with type 2 diabetes mellitus', Archives of Internal Medicine, 160(7), pp. 1009-1013. doi:10.1001/archinte.160.7.1009 Randomized trial
https://doi.org/10.1001/archinte.160.7.1009 - Ang-Lee, M.K., Moss, J. and Yuan, C.S (2001) 'Herbal medicines and perioperative care', JAMA, 286(2), pp. 208-216. doi:10.1001/jama.286.2.208 Meta-analysis / review
https://doi.org/10.1001/jama.286.2.208 - Groenewegen, W.A. and Heptinstall, S (1990) 'A comparison of the effects of an extract of feverfew and parthenolide, a component of feverfew, on human platelet activity in-vitro', Journal of Pharmacy and Pharmacology, 42(8), pp. 553-557. doi:10.1111/j.2042-7158.1990.tb07057.x Preclinical
https://doi.org/10.1111/j.2042-7158.1990.tb07057.x - Jiang, X., Williams, K.M., Liauw, W.S., Ammit, A.J., Roufogalis, B.D., Duke, C.C., Day, R.O. and McLachlan, A.J (2005) 'Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects', British Journal of Clinical Pharmacology, 59(4), pp. 425-432. doi:10.1111/j.1365-2125.2005.02322.x Randomized trial
https://doi.org/10.1111/j.1365-2125.2005.02322.x
- Motta, F., Gershwin, M.E. and Selmi, C (2021) 'Mushrooms and immunity', Journal of Autoimmunity, 117, pp. 102576. doi:10.1016/j.jaut.2020.102576 Meta-analysis / review
https://doi.org/10.1016/j.jaut.2020.102576 - Toros, G., El-Ramady, H., Prokisch, J., Velasco, F. and others (2023) 'Modulation of the Gut Microbiota with Prebiotics and Antimicrobial Agents from Pleurotus ostreatus Mushroom', Foods, 12(10), pp. 2010. doi:10.3390/foods12102010 Preclinical
https://doi.org/10.3390/foods12102010 - Mishra, V., Tomar, S., Yadav, P. and Singh, M.P (2021) 'Promising anticancer activity of polysaccharides and other macromolecules derived from oyster mushroom (Pleurotus sp.): An updated review', International Journal of Biological Macromolecules, 182, pp. 1628-1637. doi:10.1016/j.ijbiomac.2021.05.102 Meta-analysis / review
https://doi.org/10.1016/j.ijbiomac.2021.05.102 - Gu, Y.H. and Sivam, G (2006) 'Cytotoxic effect of oyster mushroom Pleurotus ostreatus on human androgen-independent prostate cancer PC-3 cells', Journal of Medicinal Food, 9(2), pp. 196-204. doi:10.1089/jmf.2006.9.196 Preclinical
https://doi.org/10.1089/jmf.2006.9.196 - Sharma, A., Sharma, A. and Tripathi, A (2021) 'Biological activities of Pleurotus spp. polysaccharides: A review', Journal of Food Biochemistry, 45(6), pp. e13748. doi:10.1111/jfbc.13748 Meta-analysis / review
https://doi.org/10.1111/jfbc.13748 - Krupodorova, T., Barshteyn, V., Tsygankova, V., Sevindik, M. and others (2024) 'Strain-specific features of Pleurotus ostreatus growth in vitro and some of its biological activities', BMC Biotechnology, 24(1), pp. 9. doi:10.1186/s12896-024-00834-9 Preclinical
https://doi.org/10.1186/s12896-024-00834-9 - Perez-Bassart, Z., Bauerl, C., Fabra, M.J., Martinez-Abad, A. and others (2023) 'Composition, structural properties and immunomodulatory activity of several aqueous Pleurotus beta-glucan-rich extracts', International Journal of Biological Macromolecules, 253(Pt 6), pp. 127255. doi:10.1016/j.ijbiomac.2023.127255 Preclinical
https://doi.org/10.1016/j.ijbiomac.2023.127255 - Dos Santos, J.F., de Oliveira, N.M.T., da Silva Milhorini, S., Rutckeviski, R. and others (2025) 'The use of Pleurotus ostreatus by-products for the preparation of a gel-like polysaccharide with bioactive properties', International Journal of Biological Macromolecules, 301, pp. 140236. doi:10.1016/j.ijbiomac.2025.140236 Preclinical
https://doi.org/10.1016/j.ijbiomac.2025.140236 - Huang, X. and Nie, S (2015) 'The structure of mushroom polysaccharides and their beneficial role in health', Food & Function, 6(10), pp. 3205-3217. doi:10.1039/c5fo00678c Meta-analysis / review
https://doi.org/10.1039/c5fo00678c - Drezek, J. and Mozejko-Ciesielska, J (2025) 'Production of beta-Glucans by Pleurotus ostreatus: Cultivation and Genetic Background', International Journal of Molecular Sciences, 26(19), pp. 9703. doi:10.3390/ijms26199703 Preclinical
https://doi.org/10.3390/ijms26199703 - Spacek, J., Vocka, M., Zavadova, E., Konopasek, B. and Petruzelka, L (2021) 'Immunomodulation with beta-glucan from Pleurotus ostreatus in patients with endocrine-dependent breast cancer', Immunotherapy, 14(1), pp. 31-40. doi:10.2217/imt-2021-0069 Clinical study
https://doi.org/10.2217/imt-2021-0069 - Majtan, J (2012) 'Pleuran (beta-glucan from Pleurotus ostreatus): an effective nutritional supplement against upper respiratory tract infections?', Medicine and Sport Science, 59, pp. 57-61. doi:10.1159/000341967 Clinical study
https://doi.org/10.1159/000341967 - Gariboldi, M.B., Marras, E., Ferrario, N., Vivona, V., Prini, P., Vignati, F. and Perletti, G (2023) 'Anti-Cancer Potential of Edible/Medicinal Mushrooms in Breast Cancer', International Journal of Molecular Sciences, 24(12), pp. 10120. doi:10.3390/ijms241210120 Preclinical
https://doi.org/10.3390/ijms241210120 - Gonmori, K. and Yokoyama, K (2009) 'Acute encephalopathy caused by cyanogenic fungi in 2004, and magic mushroom regulation in Japan', Chudoku Kenkyu, 22(1), pp. 61-9. Available at: https://pubmed.ncbi.nlm.nih.gov/19344063/ Clinical study
https://pubmed.ncbi.nlm.nih.gov/19344063/ - Wasser, S.P (2011) 'Current findings, future trends, and unsolved problems in studies of medicinal mushrooms', 89(5), pp. 1323--1332. doi:10.1007/s00253-010-3067-4 Randomized trial
https://doi.org/10.1007/s00253-010-3067-4 - Guillamon, E. et al (2010) 'Edible mushrooms: role in the prevention of cardiovascular diseases', 81(7), pp. 715--723. doi:10.1016/j.fitote.2010.06.005 Clinical study
https://doi.org/10.1016/j.fitote.2010.06.005 - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Yamamoto, N. and Suzuki, T. and Kobayashi, M. and others (2014) 'A-WINGS: an integrated genome database for Pleurocybella porrigens (angel's wing oyster mushroom, Sugihiratake)', BMC Research Notes, 7, pp. 866. doi:10.1186/1756-0500-7-866 Preclinical
https://doi.org/10.1186/1756-0500-7-866 - Mushroom Appreciation (2024) 'Angel wings vs oyster mushrooms: identification and controversy'. Available at: https://www.mushroom-appreciation.com/angel-wings-identification.html Traditional / reference
https://www.mushroom-appreciation.com/angel-wings-identification.html - Sugano, Y. and Sakata, K. and Nakamura, K. and others (2017) 'Rapid identification method of Omphalotus japonicus by PCR-RFLP', Shokuhin Eiseigaku Zasshi, 58(3), pp. 113-123. doi:10.3358/shokueishi.58.113 Preclinical
https://doi.org/10.3358/shokueishi.58.113 - Kasahara, Y (2013) 'Clinical toxicology of mushroom poisoning: Omphalotus guepiniformis', Chudoku Kenkyu, 26(3), pp. 215-8. Available at: https://pubmed.ncbi.nlm.nih.gov/24224384/ Clinical study
https://pubmed.ncbi.nlm.nih.gov/24224384/ - Mushroom Appreciation (2024) 'The jack o'lantern mushroom (Omphalotus olearius)'. Available at: https://www.mushroom-appreciation.com/omphalotus-olearius.html Traditional / reference
https://www.mushroom-appreciation.com/omphalotus-olearius.html
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.